Welcome to our dedicated page for Veeva Sys news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Sys stock.
Veeva Systems Inc. reports developments in cloud software, data, AI, and consulting for the life sciences industry. Company news commonly covers adoption of the Veeva Vault Platform, including Development Cloud, Quality Cloud, Commercial Cloud, Data Cloud, Vault CRM, and Veeva MedTech applications for clinical, regulatory, quality, commercial, and medical operations.
Updates also include customer standardization projects with pharmaceutical, biotechnology, medical device, and diagnostics companies; product and data offerings such as Link Key People and Veeva AI; fiscal results and subscription revenue trends; and corporate actions such as acquisitions, including the completed purchase of Ostro as a life sciences brand engagement platform.
Veeva Systems (NYSE: VEEV) announced that Bristol Myers Squibb (NYSE: BMY) will adopt Veeva Vault PromoMats for enhanced content delivery across digital channels. This application enables automatic generation of submission-ready forms for products, streamlining the process to meet FDA eCTD requirements. The new capability is expected to launch in December 2020, which will improve compliance and accelerate promotional material packaging for Bristol Myers Squibb. This partnership builds on Veeva's existing solutions, enhancing customer engagement and regulatory compliance.
Veeva Systems (NYSE: VEEV) has expanded its Veeva Link offering to include 11 new therapeutic areas, enhancing real-time customer intelligence for life sciences teams. The new areas cover diverse fields such as cardiology, dermatology, and neurology, building on the success of Veeva Link for Oncology, which is utilized by 6 of the top 10 pharmaceutical companies. The solutions are set to be available in March 2021, leveraging over 50,000 sources for accurate data on healthcare decision-makers.
Veeva Systems (NYSE: VEEV) announced that Bristol Myers Squibb (NYSE: BMY) will implement Veeva Vault PromoMats to enhance their promotional material process. This new capability, available in December 2020, allows for automatic generation of submission-ready forms, streamlining the approval process with the U.S. FDA. Vault PromoMats combines digital asset management with regulatory compliance to ensure efficient content distribution. This partnership aims to support Bristol Myers Squibb's needs for faster and compliant content delivery.
Veeva Systems (NYSE: VEEV) announced the expansion of Veeva Link to include 11 new therapeutic areas: bacterial infections, cardiology, dermatology, endocrinology, gastroenterology, hepatology, nephrology, neurology, respiratory, rheumatology, and virology. This enhancement aims to provide commercial and medical teams with real-time customer intelligence. Veeva Link is already utilized by six of the ten largest pharmaceutical companies, focusing on improved engagement with healthcare decision-makers. The new solutions are expected to be available in March 2021.
Veeva Systems reports that over 75 organizations, including top pharmaceutical companies, are adopting Veeva Vault CTMS to enhance clinical trial efficiency and speed. This modern cloud application is now managing nearly 50,000 clinical trials, facilitating real-time insights and proactive management. The platform integrates with Veeva Vault EDC and includes new capabilities like Vault Payments, allowing for better collaboration and compliance. The focus on streamlining operations aims to mitigate delays and improve overall study execution.
Summary not available.
Summary not available.
Axsome Therapeutics has partnered with Veeva Systems to enhance its Digital-Centric Commercialization (DCC™) platform, aimed at optimizing marketing for CNS drugs AXS-05 and AXS-07, expected to launch next year. Veeva will provide technology, data, and consulting support, leveraging its Commercial Cloud products to improve physician-patient engagement.
The partnership underscores a significant shift in commercial strategy, focusing on innovative digital tools to streamline drug promotion and improve patient care.
Veeva Systems (NYSE: VEEV) announced the participation of Dr. Francesca Domenech Wuttke and Alessandro de Luca as keynote speakers at the 2020 Veeva Commercial & Medical Summit Online, Europe. The event, featuring over 80 sessions, focuses on digital transformation in life sciences to expedite drug market entry. Notable discussions include insights from Alexion, Boehringer Ingelheim, Lundbeck Italy, and Shionogi on advancing digital strategies. Scheduled for November 17-18, 2020, the summit aims to unite over 3,000 professionals from more than 250 companies in the sector.
Veeva Systems (NYSE: VEEV) announced that Bavarian Nordic is utilizing its Veeva CRM and Veeva Vault PromoMats for a digital product launch across the U.S. and Europe, enhancing their digital engagement capabilities. Bavarian Nordic, focused on vaccines for infectious diseases, chose Veeva to meet aggressive launch timelines and support global growth. This partnership allows for effective HCP interactions through digital channels, ensuring compliance and timely content delivery, further solidifying Veeva's role in driving digital transformation within the life sciences sector.